ARTICLE | Distillery Therapeutics
Modulating RNA splicing through RBM39 and PRMT inhibition to induce tumor neoantigen expression
July 1, 2021 11:34 PM UTC
DISEASE CATEGORY: Cancer
INDICATION: Colorectal cancer; melanoma...
BCIQ Target Profiles
DISEASE CATEGORY: Cancer
INDICATION: Colorectal cancer; melanoma...
BCIQ Target Profiles
BCIQ Target Profiles